Cargando…
MicroRNAs distribution in different phenotypes of Aortic Stenosis
Aortic valve stenosis (AVS) represents a cluster of different phenotypes, considering gradient and flow pattern. Circulating micro RNAs may reflect specific pathophysiological processes and could be useful biomarkers to identify disease. We assessed 80 patients (81, 76.7–84 years; 46, 57.5%females)...
Autores principales: | Fabiani, Iacopo, Pugliese, Nicola Riccardo, Calogero, Enrico, Conte, Lorenzo, Mazzanti, Maria Chiara, Scatena, Cristian, Scopelliti, Claudia, Tantillo, Elena, Passiatore, Matteo, Angelillis, Marco, Naccarato, Giuseppe Antonio, Di Stefano, Rossella, Petronio, Anna Sonia, Di Bello, Vitantonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028376/ https://www.ncbi.nlm.nih.gov/pubmed/29967333 http://dx.doi.org/10.1038/s41598-018-28246-8 |
Ejemplares similares
-
Review in Translational Cardiology: MicroRNAs and Myocardial Fibrosis in Aortic Valve Stenosis, a Deep Insight on Left Ventricular Remodeling
por: Iacopo, Fabiani, et al.
Publicado: (2016) -
Micro-RNA-21 (biomarker) and global longitudinal strain (functional marker) in detection of myocardial fibrotic burden in severe aortic valve stenosis: a pilot study
por: Fabiani, Iacopo, et al.
Publicado: (2016) -
Growth Differentiation Factor 15 in Severe Aortic Valve Stenosis: Relationship with Left Ventricular Remodeling and Frailty
por: Fabiani, Iacopo, et al.
Publicado: (2020) -
Impact of empagliflozin on subclinical left ventricular dysfunctions and on the mechanisms involved in myocardial disease progression in type 2 diabetes: rationale and design of the EMPA-HEART trial
por: Natali, Andrea, et al.
Publicado: (2017) -
Translational Cardiovascular Imaging: A New Integrated Approach to Target Myocardial Fibrosis Turnover in Different Forms of Cardiac Remodeling
por: Di Bello, Vitantonio, et al.
Publicado: (2017)